


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.18%
+3.61%
+16.15%
-3.87%
UNH
UnitedHealth Group Incorp
$285.25
Strengths

Earnings are forecast to grow

Outperform the market

Trading below its fair value
Risk Analysis

Downgraded on weak valued

Investors losing their confidence

High risk of cutting its dividend
UNH Price Performance
$278.91 (+2.27%)
$341.84 (-16.55%)
$361.15 (-21.02%)
$518.81 (-45.02%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a weak earnings
Revenue declined YoY
Eps growth
Earnings decline YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors losing their confidence
High risk of cutting its dividend
Future
Future
Earnings are forecast to grow
Outperform the market
Trading below its fair value
UNH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
UNH Street Sentiment is bullish and have positive views on the near-term outlook
UNH has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 12, 2026
Reiterate
an Overweight
Mizuho
Jan 22, 2026
Reiterate
its Buy
Mizuho
Jan 08, 2026
Price Target Raised
Buy
Barclays
Oct 30, 2025
Reiterate
Buy
UBS
Oct 30, 2025
Reiterate
Overweight
Piper Sandler
What is UNH current stock price?
What are UNH stock strengths?
What is UNH Risk Level?
What is UNH market cap and volume?
What is UNH current Stock IQ?
Should I buy UNH stock right now?
Is UNH a Strong Buy right now?
What does a 'Strong Buy' rating mean for UNH?
What does a 'Strong Sell' rating mean for UNH?
What factors influence UNH's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
UNH
UnitedHealth Group Incorp
Current Price
$285.25

UNH Price Performance
$278.91 (+2.27%)
$341.84 (-16.55%)
$361.15 (-21.02%)
$518.81 (-45.02%)
UNH Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a weak earnings
Revenue declined YoY
Eps growth
Earnings decline YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors losing their confidence
High risk of cutting its dividend
Future
Future
Earnings are forecast to grow
Outperform the market
Trading below its fair value
UNH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
UNH Street Sentiment is bullish and have positive views on the near-term outlook
UNH has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
UNH Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Outperform the market

Trading below its fair value
Risk Analysis

Downgraded on weak valued

Investors losing their confidence

High risk of cutting its dividend
UNH Latest Analysis
Trump Ally New DHS Leader Nominee Markwayne Mullin Makes New Stock Trades: Heres What He Bought And Sold. Sen. Markwayne Mullin (R-Okla.) could become the next leader of the Department of Homeland Security as he was named recently the nominee to replace Kristi Noem by President Donald Trump. A current member of the Senate Mullin has been an active stock trader in recent years.Markwayne Mullin'.s Recent Stock TransactionsMullin made three stock trades on Feb. 25 according to data from the Ben
Tue Mar 10, 2026
UNH Deploys AI in Optum Rx to Tackle Pharmacy Fraud and Cost Leakage. UnitedHealth rolls out AI in Optum Rx to flag pharmacy fraud billing anomalies and medication risks aiming to curb cost leakage and improve compliance.
Mon Mar 9, 2026
Healthcare Jobs Drop UnitedHealth Stock Slips: Opportunity or Risk?. UNH faces rising medical costs regulatory probes and a healthcare hiring slump while shares keep falling leaving investors weighing risk or opportunity.
Mon Mar 9, 2026
Here Is Why UnitedHealth (UNH) Is Highly Favored By Billionaires. UnitedHealth Group Inc. (NYSE:UNH) is one of the 15 best stocks to invest in according to billionaires. On February 5 Mizuho Securities reduced the price target on UnitedHealth Group Inc. (NYSE:UNH) from $430 to $350. The firm maintained its Outperform rating on the shares resulting in a revised upside of more than 19%. The firm [….]
Thu Mar 5, 2026
UnitedHealth: A Golden Buying Opportunity (Rating Upgrade).
Tue Mar 3, 2026
UnitedHealth sets up mixed shelf offering.
Tue Mar 3, 2026
UnitedHealths Stock Might Not Rally Until This Number Improves.
Mon Mar 2, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.